ASCENTAGE PHARMA GROUP INTERNATIONAL
AAPG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $981 | $222 | $210 | $28 |
| % Growth | 341.8% | 5.9% | 651.4% | – |
| Cost of Goods Sold | $29 | $31 | $22 | $3 |
| Gross Profit | $952 | $191 | $188 | $25 |
| % Margin | 97% | 86.2% | 89.5% | 88.1% |
| R&D Expenses | $947 | $707 | $743 | $766 |
| G&A Expenses | $187 | $181 | $171 | $144 |
| SG&A Expenses | $383 | $376 | $328 | $191 |
| Sales & Mktg Exp. | $196 | $195 | $157 | $48 |
| Other Operating Expenses | -$9 | -$19 | -$34 | -$63 |
| Operating Expenses | $1,321 | $1,064 | $1,038 | $894 |
| Operating Income | -$370 | -$873 | -$850 | -$870 |
| % Margin | -37.7% | -393.1% | -405.2% | -3,116.6% |
| Other Income/Exp. Net | -$26 | -$60 | -$37 | $38 |
| Pre-Tax Income | -$395 | -$933 | -$887 | -$832 |
| Tax Expense | $10 | -$7 | -$4 | -$50 |
| Net Income | -$405 | -$926 | -$883 | -$782 |
| % Margin | -41.3% | -417% | -421% | -2,803.4% |
| EPS | -1.34 | -13.12 | -13.4 | -12.28 |
| % Growth | 89.8% | 2.1% | -9.1% | – |
| EPS Diluted | -1.34 | -13.12 | -13.4 | -12.28 |
| Weighted Avg Shares Out | 302 | 71 | 66 | 64 |
| Weighted Avg Shares Out Dil | 302 | 71 | 66 | 64 |
| Supplemental Information | – | – | – | – |
| Interest Income | $38 | $32 | $10 | $7 |
| Interest Expense | $64 | $96 | $53 | $17 |
| Depreciation & Amortization | $93 | $93 | $47 | $17 |
| EBITDA | -$238 | -$744 | -$787 | -$798 |
| % Margin | -24.2% | -335% | -375.3% | -2,860.4% |